Brightpoint, Inc. (CELL) Misses Q1 Estimates
Brightpoint, Inc. (Nasdaq: CELL) reports Q1 EPS of $0.09, 3 cents below the analyst estimate of $0.12. Revenues for the quarter were $1.2 billion, versus the consensus of $1.38 billion.
Related Categories
EarningsStocks Mentioned
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
